美敦力(MDT)
搜索文档
Medtronic(MDT) - 2022 Q2 - Earnings Call Transcript
2021-11-24 02:05
Medtronic plc (NYSE:MDT) Q2 2022 Earnings Conference Call November 23, 2021 8:00 AM ET Company Participants Ryan Weispfenning - Vice President & Head of Investor Relations Geoffrey Martha - Chairman & Chief Executive Officer Karen Parkhill - Chief Financial Officer Sean Salmon - EVP & President of the Cardiovascular and Diabetes Operating Unit Bob White - EVP & President of Medical Surgical Portfolio Brett Wall - EVP & President of Neuroscience Portfolio Conference Call Participants Robbie Marcus - JPMorga ...
Medtronic(MDT) - 2021 Q2 - Quarterly Report
2020-12-04 05:15
- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ® FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 30, 2020 ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from __________ to __________ Commission File Number 001-36820 MEDTRONIC PUBLIC LIMITED COMPANY (Exact name of registrant as specified in its charter) Ireland 98-1183488 (State o ...
Medtronic(MDT) - 2021 Q1 - Quarterly Report
2020-09-04 04:14
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ® FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2020 ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from __________ to __________ Commission File Number 001-36820 MEDTRONIC PUBLIC LIMITED COMPANY (Exact name of registrant as specified in its charter) Ireland 98-1183488 (State of inc ...
Medtronic(MDT) - 2020 Q4 - Annual Report
2020-06-20 04:28
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934. For the fiscal year ended April 24, 2020. ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from __________ to __________ Commission File No. 1-36820 ® MEDTRONIC PUBLIC LIMITED COMPANY (Exact name of registrant as specified in its charter) Ireland 98-11834 ...
Medtronic(MDT) - 2020 Q3 - Quarterly Report
2020-02-28 19:49
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ® FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 24, 2020 ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from __________ to __________ Commission File Number 001-36820 MEDTRONIC PUBLIC LIMITED COMPANY (Exact name of registrant as specified in its charter) Ireland 98-1183488 (State of ...